Posts With Tag enGene Holdings Inc.

Discover critical updates from enGene Holdings Inc.'s December 2024 8-K filing, detailing stock and warrant information crucial for investors and market analysts.

Explore enGene Holdings Inc.'s latest SEC report detailing a $55.1M net loss, $229.6M in cash, and R&D focus, highlighting key insights for investors considering a 'hold' recommendation.